URANIUM ENERGY CORP quarterly report, Q3 FY2024

Uranium Energy Corp. — Form 10-Q Summary

Reporting period: Fiscal third quarter and nine months ended April 30, 2024. Financial figures below are in U.S. dollars; amounts are shown in millions unless stated otherwise. The interim statements are unaudited.

Business context and reporting period

The company explores, develops and extracts uranium and conducts related processing activities in the United States, Canada and Paraguay. It remains an SEC-defined Exploration Stage issuer and has not established proven or probable reserves through a final or bankable feasibility study for any of its projects. It reported no purchased-uranium inventory sales in the first nine months of fiscal 2024.

Financial performance and liquidity

Metric	Three months ended Apr. 30, 2024	Nine months ended Apr. 30, 2024	Comparable 2023 period
Revenue	$0	$0.224	$20.217 and $125.440
Gross profit	$0	$0.037	$6.219 and $34.647
Operating loss	$13.841	$37.345	$3.484 operating loss and $5.197 operating income
Net loss	$19.677	$14.106	$10.960 and $3.824
Basic and diluted loss per share	$0.05	$0.04	$0.03 and $0.01

Quarterly revenue was nil; nine-month revenue consisted of $0.224 million from toll processing. The comparative 2023 revenue was largely from purchased uranium sales. Gross margin was not meaningful in the quarter with no revenue; nine-month gross profit was $0.037 million on $0.224 million revenue.

Cash flow, nine months: Operating activities used $93.871 million, including $57.179 million for increased uranium inventory. Financing provided $159.292 million, primarily from equity issuance; investing used $23.282 million. Cash, cash equivalents and restricted cash ended at $94.977 million, including $87.726 million of unrestricted cash.
Liquidity: Current assets were $155.474 million and current liabilities $14.312 million, for working capital of $141.162 million. Management believes available cash and, if needed, sales of liquid assets can fund planned operations for 12 months from issuance of the report.
Assets and obligations: Total assets were $878.268 million and equity $778.640 million. Total liabilities were $99.628 million, including $19.374 million of asset retirement obligations, $65.902 million of deferred tax liabilities and $8.068 million of current derivative liabilities. No material debt balance is identified in the presented balance sheet.
Uranium inventory: The company held 1.166 million pounds of purchased uranium concentrate, carried at $63.019 million, versus $5.801 million at July 31, 2023. It had additional purchase commitments for 1.0 million pounds costing $39.095 million, scheduled through fiscal 2026.

Material changes versus prior comparable periods

Revenue fell sharply because the company made no purchased-uranium sales in fiscal 2024 to date; nine-month revenue declined from $125.440 million to $0.224 million.
Nine-month operating results shifted from $5.197 million of operating income to a $37.345 million operating loss. Mineral property expenditures increased to $21.448 million from $13.650 million, while general and administrative expense was broadly level at $14.314 million.
Nine-month net loss increased to $14.106 million from $3.824 million. Results included a $23.585 million unrealized gain on equity securities and a $9.892 million loss from revaluation of derivative liabilities. In the quarter, the equity-securities revaluation produced a $13.804 million loss.
Cash increased from $45.614 million at July 31, 2023 to $87.726 million at April 30, 2024, principally supported by $155.050 million of net ATM offering proceeds during the nine months. Shares outstanding rose from 378.5 million to 406.0 million; 408.8 million were outstanding June 7, 2024.

Outlook, management commentary, risks and contingencies

The company announced a restart of uranium extraction at its fully permitted Christensen Ranch Mine in Wyoming. First extraction was expected in August 2024, with funding from existing cash. It applied to increase the licensed capacity of the Irigaray processing plant from 2.5 million to 4.0 million pounds U₃O₈ annually; approval was expected later in 2024. These are expectations, not guaranteed outcomes.
Management cited uranium market strength, with reported average prices of $92.80 per pound in the quarter and $81.64 for the nine months; the price was $90.00 per pound at April 30, 2024. The company had no uranium supply or off-take agreements in place and expects future sales generally to depend on the spot market.
Management says the business is capital-intensive, has not achieved consistent profitability or positive operating cash flow, and expects reliance on equity or other financing to continue. Beyond the stated 12-month liquidity horizon, continued operations depend on inventory sales, additional financing and ultimately achieving profitable operations.
Key operating risks include uranium-price volatility, permitting and regulatory changes, extraction and project-development uncertainty, and the absence of established proven or probable reserves. The company also notes that physical uranium may be difficult to sell promptly and that storage, counterparty and price risks may affect its inventory program.
Legal and regulatory matters include a contested renewal application for Goliad Project disposal-well permits; the Texas administrative law judges recommended remand, while the TCEQ executive director disagreed, with a commission decision expected in mid-June 2024. In Paraguay, the mining regulator disputes eligibility for extensions or exploitation of certain concessions; the company has filed applications and appeals.
Material contractual obligations totaled $70.715 million, including $39.095 million of uranium purchases, $29.030 million of undiscounted asset-retirement cash flows and $2.590 million of lease obligations. The company also disclosed that approximately $73.6 million of cash equivalents was held at one Canadian financial institution, creating concentration risk.

Important facts for investors to verify

Whether Christensen Ranch began extraction as expected in August 2024, and whether production, processing and costs meet management’s plans.
Whether the Irigaray capacity increase and Goliad permit matters received the anticipated regulatory decisions, and the status of Paraguay concession appeals.
Future uranium inventory sales, realizable prices and cash conversion, including the timing and funding of remaining purchase commitments.
Cash burn, additional financing needs and dilution from ATM sales or exercises of outstanding options and warrants.
Progress toward commercially recoverable reserves, positive operating cash flow and sustained profitability; the filing does not provide production guidance or an assured path to these outcomes.